|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 19117 |
FusionGeneSummary for KMT2C_CALN1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: KMT2C_CALN1 | Fusion gene ID: 19117 | Hgene | Tgene | Gene symbol | KMT2C | CALN1 | Gene ID | 58508 | 83698 |
| Gene name | lysine methyltransferase 2C | calneuron 1 | |
| Synonyms | HALR|KLEFS2|MLL3 | CABP8 | |
| Cytomap | 7q36.1 | 7q11.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | histone-lysine N-methyltransferase 2CALR-like proteinhistone-lysine N-methyltransferase MLL3histone-lysine N-methyltransferase, H3 lysine-4 specifichomologous to ALR proteinlysine (K)-specific methyltransferase 2Cmyeloid/lymphoid or mixed-lineage le | calcium-binding protein 8calcium-binding protein CABP8calneuron I | |
| Modification date | 20180523 | 20180519 | |
| UniProtAcc | Q8NEZ4 | Q9BXU9 | |
| Ensembl transtripts involved in fusion gene | ENST00000262189, ENST00000355193, ENST00000485655, ENST00000485241, | ENST00000329008, ENST00000395275, ENST00000395276, ENST00000405452, ENST00000412588, ENST00000431984, | |
| Fusion gene scores | * DoF score | 18 X 16 X 10=2880 | 3 X 3 X 3=27 |
| # samples | 22 | 3 | |
| ** MAII score | log2(22/2880*10)=-3.71049338280502 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: KMT2C [Title/Abstract] AND CALN1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | BRCA | TCGA-AO-A124-01A | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000262189 | ENST00000329008 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000262189 | ENST00000395275 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000262189 | ENST00000395276 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000262189 | ENST00000405452 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000262189 | ENST00000412588 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000262189 | ENST00000431984 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000329008 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000395275 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000395276 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000405452 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000412588 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| Frame-shift | ENST00000355193 | ENST00000431984 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000329008 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000395275 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000395276 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000405452 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000412588 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485655 | ENST00000431984 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000329008 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000395275 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000395276 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000405452 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000412588 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
| intron-3CDS | ENST00000485241 | ENST00000431984 | KMT2C | chr7 | 151859202 | - | CALN1 | chr7 | 71571279 | - |
Top |
FusionProtFeatures for KMT2C_CALN1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| KMT2C | CALN1 |
| Histone methyltransferase. Methylates 'Lys-4' of histoneH3. H3 'Lys-4' methylation represents a specific tag forepigenetic transcriptional activation. Central component of theMLL2/3 complex, a coactivator complex of nuclear receptors,involved in transcriptional coactivation. KMT2C/MLL3 may be acatalytic subunit of this complex. May be involved inleukemogenesis and developmental disorder.{ECO:0000269|PubMed:17500065}. | Negatively regulates Golgi-to-plasma membranetrafficking by interacting with PI4KB and inhibiting its activity(By similarity). May play a role in the physiology of neurons andis potentially important in memory and learning. {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for KMT2C_CALN1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for KMT2C_CALN1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| KMT2C | AK1, NCOA6, ASH2L, RBBP5, HIST2H3C, ASCL2, KDM6A, SMARCB1, MAPK14, JUN, PAXIP1, H3F3A, PAGR1, WDR82, CDC73, TSC22D1, KDM4B, ELAVL1, WDR5, HIST1H3A, APPL2, ERP44, HIST3H3, DPY30, MTNR1B, FOXA1, TRIM25 | CALN1 | DCAF6 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for KMT2C_CALN1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for KMT2C_CALN1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | KMT2C | C0001418 | Adenocarcinoma | 1 | CTD_human |
| Hgene | KMT2C | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | KMT2C | C0007138 | Carcinoma, Transitional Cell | 1 | CTD_human |
| Hgene | KMT2C | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | KMT2C | C0023467 | Leukemia, Myelocytic, Acute | 1 | CTD_human |
| Hgene | KMT2C | C0023897 | Liver Diseases, Parasitic | 1 | CTD_human |
| Hgene | KMT2C | C0036920 | Sezary Syndrome | 1 | CTD_human |
| Hgene | KMT2C | C0038356 | Stomach Neoplasms | 1 | CTD_human |
| Hgene | KMT2C | C0206698 | Cholangiocarcinoma | 1 | CTD_human |
| Hgene | KMT2C | C0279626 | Squamous cell carcinoma of esophagus | 1 | CTD_human |
| Hgene | KMT2C | C2239176 | Liver carcinoma | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|